A/Prof Richard Gallagher OAM, ENT surgeon, St Vincent's Hospital Sydney: head and neck, thyroid and salivary gland surgery

A/Prof Richard Gallagher OAM

Head and neck, thyroid and salivary gland surgery. MBBS, FRACS

Associate Professor Richard Gallagher OAM is a head and neck surgeon at St Vincent’s Hospital, Sydney. A graduate of the University of New South Wales, he completed his surgical training in Australia in 1995 and is a Fellow of the Royal Australasian College of Surgeons. He undertook year-long fellowships in head and neck surgery at Princess Alexandra Hospital, Brisbane, and in sinus and skull base surgery at the University of Virginia, Charlottesville, in the United States. His practice covers malignant and benign head and neck disease, with particular interests in HPV-related cancers of the throat, transoral robotic surgery, voice and airway surgery including tracheal stenosis, thyroid surgery, parotid and submandibular gland surgery, and sinus, nasal and skull base surgery. He is Chair of the St Vincent’s Head and Neck Multidisciplinary Team at The Kinghorn Cancer Centre, a previous Director of Cancer Services at St Vincent’s Private Hospital, and Adjunct Associate Professor at the University of Notre Dame Australia; he established the St Vincent’s Sinus Surgery Course, the St Vincent’s Head and Neck Dissection Course and the ENT outreach clinic in Moree.

At St Vincent’s

Public clinics through St Vincent’s Hospital ENT outpatients; referrals through the St Vincent’s Hospital ENT page.

Private rooms

St Vincent’s Clinic, Suite 1002B, 438 Victoria Street, Darlinghurst NSW 2010

Tel +61 2 8382 6010 · Fax +61 2 8382 6012

Selected publications

  1. Chin VT, Muskovic W, McCloy RA et al. Protein translation dysregulation and immune cell evasion mediated by IFN and immunoproteasome downregulation define metastatic clones in HPV-related cancer of the oropharynx. BMC Med 2025;23(1):559. doi
  2. Kornfeld B, Taha A, Kyang L et al. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study. J Robot Surg 2024;18(1):226. doi
  3. Kornfeld B, Kyang L, Taha A et al. Incidence and distribution of contralateral lymph node metastasis associated with HPV-related oropharyngeal squamous cell carcinoma. J Laryngol Otol 2024;138(9):965-972. doi
  4. Kornfeld B, Floros P, Gallagher R. Transoral robotic resection for parapharyngeal space tumours. In: Costello A, ed. Principles and Practice of Robotic Surgery, chapter 46. Elsevier, Philadelphia, 2024. ISBN 978-0-323-79820-4.
  5. Nindra U, Hurwitz J, Forstner D et al. A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma. Cancer Med 2023;12(10):11234-11247. doi
  6. Hardingham N, Ward E, Clayton N, Gallagher R. Acute swallowing outcomes after surgical resection of oral cavity and oropharyngeal cancers with the mandibular lingual release approach. Otolaryngol Head Neck Surg 2023;169(2):286-293. doi
  7. Nieto P, Elosua-Bayes M, Trincado JL et al. A single-cell tumor immune atlas for precision oncology. Genome Res 2021;31(10):1913-1926. doi
  8. Floros P, Rao A, McCloy RA et al. Altered presentation of oropharyngeal cancer, a 6-year review. ANZ J Surg 2021;91(6):1240-1245. doi
  9. Waterboer T, Brenner N, Gallagher R et al. Early detection of human papillomavirus-driven oropharyngeal cancer using serology from the Study of Prevention of Anal Cancer. JAMA Oncol 2020;6(11):1806-1808. doi
  10. Lee J, Emmett L, Tang R et al. Prospective evaluation of the impact of human papilloma virus status and small node size on the diagnostic accuracy of 18F-FDG PET/CT for primary head and neck squamous cell carcinoma. ANZ J Surg 2020;90(7-8):1396-1401. doi

Full publication list: ORCID · PubMed